Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Jason Hoitt

Chief Patient Officer at Stoke Therapeutics, Inc. (STOK)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $119K

Reported trades

Filed Stock Type Shares Price Value Since
Mar 19SEC STOKStoke Therapeutics, Inc. Sell 1,03312,955 held (−7%) $32.74 $34K -24.4%
Mar 19SEC STOKStoke Therapeutics, Inc. Sell 74812,207 held (−6%) $33.38 $25K -25.9%
Mar 19SEC STOKStoke Therapeutics, Inc. Sell 1,76210,445 held (−14%) $31.28 $55K -20.9%
Mar 19SEC STOKStoke Therapeutics, Inc. Sell 13910,306 held (−1%) $31.79 $4K -22.2%
Mar 19SEC STOKStoke Therapeutics, Inc. Sell 3010,276 held (−0%) $32.85 $986 -24.7%